UFP-512

UFP-512 has been studied in 1 paper since 2025: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Oct 23, 2025: “Delta-opioid receptor ameliorates microglia-induced synapse loss by regulating C1q in Alzheimer disease pathology”.

Intervention

1 paper studies it4 findingsUpdated

PubChem

More peptides

See all 1 papers on UFP-512

At a glance

The findings reach mice, none yet in people. 1 lab in 1 country.

None of its findings points the other way.

Mice: a single group. Cells, worms or flies and humans: nothing yet.
  • 1 lab in 1 country
  • Funders: Changzhou Science and Technology Bureau and 3 more
  • Animals1

What did studies of UFP-512 find?

4

Studies of UFP-512 measured 4 outcomes, among them cognitive function, synaptic protein loss and complement system.

Cognitive function

upin mice1

1 study
  1. UFP-512 improves cognitive function in mice (APP/PS1 mice).

    “consequently improved cognitive performance of these Alzheimer's disease (AD) mice”

    AnimalsAPP/PS1 mice

    Delta-opioid receptor ameliorates microglia-induced synapse loss by regulating C1q in Alzheimer disease pathology

    Brain, behavior, and immunity

Synaptic protein loss

downin mice1

1 study
  1. UFP-512 prevents synaptic protein loss in mice (APP/PS1 mice).

    “prevented synaptic protein loss”

    AnimalsAPP/PS1 mice

    Delta-opioid receptor ameliorates microglia-induced synapse loss by regulating C1q in Alzheimer disease pathology

    Brain, behavior, and immunity

Complement system

downin mice1

1 study
  1. UFP-512 inhibits complement system in mice (DOR-C1q interaction in UFP-512-treated APP/PS1 mice).

    “This interaction subsequently suppressed CCP activation”

    AnimalsDOR-C1q interaction in UFP-512-treated APP/PS1 mice

    Delta-opioid receptor ameliorates microglia-induced synapse loss by regulating C1q in Alzheimer disease pathology

    Brain, behavior, and immunity

More on Complement system

C1q

downin mice1

1 study
  1. UFP-512 decreases C1q in mice (APP/PS1 transgenic mice).

    “Activating DOR with the specific agonist UFP-512 in aged APP/PS1 mice reduced cerebral C1q levels”

    AnimalsAPP/PS1 transgenic micebrain

    Delta-opioid receptor ameliorates microglia-induced synapse loss by regulating C1q in Alzheimer disease pathology

    Brain, behavior, and immunity

More on C1q

Latest